Literature DB >> 16801336

Cancer initiatives in developing countries.

H Mellstedt1.   

Abstract

The coming decades will bring dramatic increases in morbidity and mortality from cancer in the developing world. The burden of cancer is increasing globally, with an expected 20 million new cases per year in 2020, half of which will be in low- and middle-income countries. Despite an already overwhelming burden of health problems, developing countries must somehow address this cancer pandemic and their alarming share of cancer illness. Many large-scale and innovative worldwide initiatives have been launched in the fight against cancer. These programs represent colossal efforts to expand resources for health education among people and healthcare workers in developing countries and to increase awareness of cancer prevention. Many novel evidence-based and culturally-relevant programs are being implemented for screening and early prevention of common cancers. Several key initiatives are supporting clinical research, guideline development, oncology training, and appropriate technology transfer, such as access to electronic medical literature. Treatment programs are expanding access and quality of radiologic and pharmacologic therapies for cancer. These initiatives represent an unprecedented level of and cooperation among international agencies, governmental and nongovernmental organizations, international foundations, scientific societies, local institutions, and industry. This review examines the scope of need in response to the increasing burden of cancer in the developing world and major initiatives that have been created to respond to these needs.

Entities:  

Mesh:

Year:  2006        PMID: 16801336     DOI: 10.1093/annonc/mdl984

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  18 in total

1.  Breast Cancer Systemic Therapy: The Need for More Economically Sustainable Scientific Strategies in the World.

Authors:  Ahmed Elzawawy
Journal:  Breast Care (Basel)       Date:  2008-11-25       Impact factor: 2.860

2.  Cancer care inequity for women in resource-poor countries.

Authors:  Joyce Varughese; Susan Richman
Journal:  Rev Obstet Gynecol       Date:  2010

3.  Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.

Authors:  Emma Crutchlow; Yohannie Miombe; Tom Latham
Journal:  Malawi Med J       Date:  2008-12       Impact factor: 0.875

4.  Defining a global research agenda for breast cancer.

Authors:  Richard R Love
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

5.  Tobacco and the escalating global cancer burden.

Authors:  Richard F Oppeltz; Ismail Jatoi
Journal:  J Oncol       Date:  2011-08-18       Impact factor: 4.375

6.  ABL-N-induced apoptosis in human breast cancer cells is partially mediated by c-Jun NH2-terminal kinase activation.

Authors:  Bin Liu; Mei Han; Rong-Hua Sun; Jun-Jie Wang; Yan-Ping Zhang; Di-Qun Zhang; Jin-Kun Wen
Journal:  Breast Cancer Res       Date:  2010-01-25       Impact factor: 6.466

7.  Ovarian cancer survival population differences: a "high resolution study" comparing Philippine residents, and Filipino-Americans and Caucasians living in the US.

Authors:  Maria Theresa M Redaniel; Adriano Laudico; Maria Rica Mirasol-Lumague; Adam Gondos; Gemma Leonora Uy; Jean Ann Toral; Doris Benavides; Hermann Brenner
Journal:  BMC Cancer       Date:  2009-09-24       Impact factor: 4.430

8.  The suitability of using death certificates as a data source for cancer mortality assessment in Turkey.

Authors:  Tumer Ulus; Eray Yurtseven; Sabanur Cavdar; Ethem Erginoz; M Sarper Erdogan
Journal:  Croat Med J       Date:  2012-10       Impact factor: 1.351

9.  Early results of prostate cancer radiation therapy: an analysis with emphasis on research strategies to improve treatment delivery and outcomes.

Authors:  Kosj Yamoah; Kwamena Beecham; Sarah E Hegarty; Terry Hyslop; Timothy Showalter; Joel Yarney
Journal:  BMC Cancer       Date:  2013-01-16       Impact factor: 4.430

10.  Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program.

Authors:  Ebru Tekinturhan; Etienne Audureau; Marie-Pierre Tavolacci; Patricia Garcia-Gonzalez; Joël Ladner; Joseph Saba
Journal:  BMC Health Serv Res       Date:  2013-08-10       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.